[1] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版). 实用肝脏病杂志,2013,16:210-216.
[2] Zheng YB,Huang ZL,Wu ZB, et al. Dynamic changes of clinical features that predict the prognosis of acute-on-chronic hepatitis B liver failure: a retrospective cohort study. Int J Med Sci,2013,10:1658-1664.
[3] 汪徐林,邵建国,陈智娴,等.人工肝支持系统治疗对慢加急性肝衰竭病死率影响的Meta分析. 中国医师杂志,2016,18:338-342,346.
[4] Kamath PS,Wiesner RH,Malinchoc M,et al. A model to predict survival in patients with end-stage liver disease. Hepatology,2001,33:464-470.
[5] Christensen E,Schlichting P,Fauerholdt L,et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology,1984,4:430-435.
[6] Tibbs C,Williams R. Viral cases and management of acute liver failure. Hepatology,1995,22: 68-73.
[7] Moreau R,Jalan R,et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decom-pensation of cirrhosis. Gastroenterology,2013,144:1426-1437.
[8] 谢莹,吴志勤,徐文胜,等. MELD和SOFA评分系统对预测慢加急性肝衰竭患者短期预后的临床应用价值. 肝脏,2016,21:620-622,629.
[9] 陈铿,曹欣,郑茵,等.MELD-Na与CTP评分评估乙型肝炎慢加急性肝衰竭短期预后的对比研究. 中华肝脏病杂志,2014,22:801-805.
[10] Luca A,Angermayr B,Bertolini G,et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl,2007,13:1174-1180.
[11] Wu T,Li J,Shao L,et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut,2018,67:2181-2191.
[12] 朱永芬,田德英,许东,等.急性肝功能衰竭大鼠内毒素血症对肝脏和肾脏糖异生功能的影响. 中华肝脏病杂志,2007,15:672-675.
[13] 钱志平,陈楠,梅雪,等.血浆透析滤过治疗HBV相关慢加急性肝衰竭预后的影响因素分析. 肝脏,2017,22:111-115.
[14] 刘宝荣,方建凯,林明华,等.应用人工神经网络评估乙型肝炎慢加急性肝衰竭发生肝性脑病的危险因素. 肝脏,2017,22:1085-1089,1093. |
